|
Main
|
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
ClinicalTrials.gov |
|
Last refreshed on:
|
19 February 2015 |
|
Main ID: |
NCT00018109 |
|
Date of registration:
|
03/07/2001 |
|
Prospective Registration:
|
No |
|
Primary sponsor: |
|
|
Public title:
|
A Multicenter Randomized Placebo-Controlled Double-Blind Study to Assess Efficacy and Safety of Glutamine and Creatine Monohydrate in Duchenne Muscular Dystrophy (DMD)
|
|
Scientific title:
|
A Multicenter Randomized Placebo-Controlled Double-Blind Study to Assess Efficacy and Safety of Glutamine and Creatine Monohydrate in Duchenne Muscular Dystrophy (DMD) |
|
Date of first enrolment:
|
June 2001 |
|
Target sample size:
|
|
|
Recruitment status: |
Completed |
|
URL:
|
http://clinicaltrials.gov/show/NCT00018109 |
|
Study type:
|
Interventional |
|
Study design:
|
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Masking: Double-Blind, Primary Purpose: Treatment
|
|
Phase:
|
Phase 3
|
|
|
Countries of recruitment
|
|
United States
| | | | | | | |
|
Key inclusion & exclusion criteria
|
Ambulant children age 5-10 years with an established diagnosis of Duchenne Muscular
Dystrophy
Age minimum:
5 Years
Age maximum:
10 Years
Gender:
Male
|
|
Health Condition(s) or Problem(s) studied
|
|
Muscular Dystrophy, Duchenne
|
|
Intervention(s)
|
|
Drug: creatine monohydrate
|
|
Drug: glutamine
|
|
Secondary ID(s)
|
|
NCRR-M01RR00036-5083
|
|
Source(s) of Monetary Support
|
|
Please refer to primary and secondary sponsors
|
|
Results
|
|
Results available:
|
|
|
Date Posted:
|
|
|
Date Completed:
|
|
|
URL:
|
|
|
|